{
    "2020-09-07": [
        [
            {
                "time": "2020-09",
                "original_text": "多只疫苗股9月止跌上涨，疫情下流感疫苗企业或迎来放量契机",
                "features": {
                    "keywords": [
                        "疫苗",
                        "流感疫苗",
                        "放量契机"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08",
                "original_text": "【国元医药|行业追踪】疫苗行业追踪：2020年08月疫苗行业批签发数据追踪",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "行业追踪"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09",
                "original_text": "国泰君安证券：医药股二季度恢复符合预期 9月初估值较前期高点已有明显回落",
                "features": {
                    "keywords": [
                        "医药股",
                        "二季度",
                        "估值回落"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-08",
                "original_text": "前8月20只股基涨超80% 招商工银广发等基金领涨",
                "features": {
                    "keywords": [
                        "股基",
                        "涨幅",
                        "基金"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09",
                "original_text": "【医药】医药行业9月投资策略暨财报总结",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "财报总结"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}